Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
PLoS Med
    September 2022
  1. GRAM MA, Emborg HD, Schelde AB, Friis NU, et al
    Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    PLoS Med. 2022;19:e1003992.
    >> Share

  2. FOFANA MO, Nery N Jr, Aguilar Ticona JP, de Andrade Belitardo EMM, et al
    Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional survey.
    PLoS Med. 2022;19:e1004093.
    >> Share

    August 2022
  3. SAARINEN S, Moustgaard H, Remes H, Sallinen R, et al
    Income differences in COVID-19 incidence and severity in Finland among people with foreign and native background: A population-based cohort study of individuals nested within households.
    PLoS Med. 2022;19:e1004038.
    >> Share

  4. KIM S, Headley TY, Tozan Y
    Universal healthcare coverage and health service delivery before and during the COVID-19 pandemic: A difference-in-difference study of childhood immunization coverage from 195 countries.
    PLoS Med. 2022;19:e1004060.
    >> Share

  5. AHMED T, Roberton T, Vergeer P, Hansen PM, et al
    Healthcare utilization and maternal and child mortality during the COVID-19 pandemic in 18 low- and middle-income countries: An interrupted time-series analysis with mathematical modeling of administrative data.
    PLoS Med. 2022;19:e1004070.
    >> Share

  6. MODY A, Bradley C, Redkar S, Fox B, et al
    Quantifying inequities in COVID-19 vaccine distribution over time by social vulnerability, race and ethnicity, and location: A population-level analysis in St. Louis and Kansas City, Missouri.
    PLoS Med. 2022;19:e1004048.
    >> Share

  7. NIJMAN RG, Honeyford K, Farrugia R, Rose K, et al
    Presentations of children to emergency departments across Europe and the COVID-19 pandemic: A multinational observational study.
    PLoS Med. 2022;19:e1003974.
    >> Share

    July 2022
  8. REZEL-POTTS E, Douiri A, Sun X, Chowienczyk PJ, et al
    Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK.
    PLoS Med. 2022;19:e1004052.
    >> Share

  9. COBB NL, Collier S, Attia EF, Augusto O, et al
    Global influenza surveillance systems to detect the spread of influenza-negative influenza-like illness during the COVID-19 pandemic: Time series outlier analyses from 2015-2020.
    PLoS Med. 2022;19:e1004035.
    >> Share

  10. SHIBUYA K, Tan CC, Chun AY, Leung GM, et al
    Global human security in the post-COVID-19 era: The rising role of East Asia.
    PLoS Med. 2022;19:e1003939.
    >> Share

  11. HERNANDEZ I, Dickson S, Tang S, Gabriel N, et al
    Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional study.
    PLoS Med. 2022;19:e1004069.
    >> Share

  12. MASSARI M, Spila Alegiani S, Morciano C, Spuri M, et al
    Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
    PLoS Med. 2022;19:e1004056.
    >> Share

    June 2022
  13. TAKUVA S, Takalani A, Seocharan I, Yende-Zuma N, et al
    Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.
    PLoS Med. 2022;19:e1004024.
    >> Share

  14. WONG CKH, Lau KTK, Xiong X, Au ICH, et al
    Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
    PLoS Med. 2022;19:e1004018.
    >> Share

  15. CUIJPERS P, Heim E, Abi Ramia J, Burchert S, et al
    Effects of a WHO-guided digital health intervention for depression in Syrian refugees in Lebanon: A randomized controlled trial.
    PLoS Med. 2022;19:e1004025.
    >> Share

  16. GRAIS RF, Baron E
    Addressing the impacts of COVID-19 on refugee health.
    PLoS Med. 2022;19:e1004050.
    >> Share

    May 2022
  17. MARTIN CA, Pan D, Melbourne C, Teece L, et al
    Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis.
    PLoS Med. 2022;19:e1004015.
    >> Share

  18. JIN P, Guo X, Chen W, Ma S, et al
    Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial.
    PLoS Med. 2022;19:e1003953.
    >> Share

  19. VAN GILS MJ, Lavell A, van der Straten K, Appelman B, et al
    Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study.
    PLoS Med. 2022;19:e1003991.
    >> Share

  20. ALTARE C, Kostandova N, OKeeffe J, Hayek H, et al
    COVID-19 epidemiology and changes in health service utilization in Azraq and Zaatari refugee camps in Jordan: A retrospective cohort study.
    PLoS Med. 2022;19:e1003993.
    >> Share

  21. ANNWEILER C, Beaudenon M, Gautier J, Gonsard J, et al
    High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial.
    PLoS Med. 2022;19:e1003999.
    >> Share

  22. BUITRAGO-GARCIA D, Ipekci AM, Heron L, Imeri H, et al
    Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis.
    PLoS Med. 2022;19:e1003987.
    >> Share

  23. MACHADO DB, Williamson E, Pescarini JM, Alves FJO, et al
    Relationship between the Bolsa Familia national cash transfer programme and suicide incidence in Brazil: A quasi-experimental study.
    PLoS Med. 2022;19:e1004000.
    >> Share

  24. BRUMMER LE, Katzenschlager S, McGrath S, Schmitz S, et al
    Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing influencing factors.
    PLoS Med. 2022;19:e1004011.
    >> Share

    April 2022
  25. FOO D, Sarna M, Pereira G, Moore HC, et al
    Prenatal influenza vaccination and allergic and autoimmune diseases in childhood: A longitudinal, population-based linked cohort study.
    PLoS Med. 2022;19:e1003963.
    >> Share

  26. WATKINSON RE, Williams R, Gillibrand S, Sanders C, et al
    Correction: Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study.
    PLoS Med. 2022;19:e1003982.
    >> Share

  27. WAINSTEIN M, MacDonald S, Fryer D, Young K, et al
    Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol.
    PLoS Med. 2022;19:e1003969.
    >> Share

    March 2022
  28. WATKINSON RE, Williams R, Gillibrand S, Sanders C, et al
    Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study.
    PLoS Med. 2022;19:e1003932.
    >> Share

  29. WANG C, Ong JJ, Zhao P, Weideman AM, et al
    Expanding syphilis test uptake using rapid dual self-testing for syphilis and HIV among men who have sex with men in China: A multiarm randomized controlled trial.
    PLoS Med. 2022;19:e1003930.
    >> Share

  30. MAURIN C, He Z, Mentek M, Verhoeven P, et al
    Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study.
    PLoS Med. 2022;19:e1003922.
    >> Share

  31. GIMMA A, Munday JD, Wong KLM, Coletti P, et al
    Changes in social contacts in England during the COVID-19 pandemic between March 2020 and March 2021 as measured by the CoMix survey: A repeated cross-sectional study.
    PLoS Med. 2022;19:e1003907.
    >> Share

    February 2022
  32. SAAKSVUORI L, Betsch C, Nohynek H, Salo H, et al
    Information nudges for influenza vaccination: Evidence from a large-scale cluster-randomized controlled trial in Finland.
    PLoS Med. 2022;19:e1003919.
    >> Share

  33. Vaccine equity: A fundamental imperative in the fight against COVID-19.
    PLoS Med. 2022;19:e1003948.
    >> Share

  34. KONTOPANTELIS E, Mamas MA, Webb RT, Castro A, et al
    Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation, and region in England and Wales during 2020: A registry-based study.
    PLoS Med. 2022;19:e1003904.
    >> Share

  35. CAUSEY K, Mosser JF
    Learning from the COVID-19 pandemic to strengthen routine immunization systems.
    PLoS Med. 2022;19:e1003934.
    >> Share

  36. MCQUAID F, Mulholland R, Sangpang Rai Y, Agrawal U, et al
    Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data.
    PLoS Med. 2022;19:e1003916.
    >> Share

  37. KERR S, Joy M, Torabi F, Bedston S, et al
    First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales.
    PLoS Med. 2022;19:e1003927.
    >> Share

    January 2022
  38. GENTILE I, Schiano Moriello N
    COVID-19 prophylaxis in immunosuppressed patients: Beyond vaccination.
    PLoS Med. 2022;19:e1003917.
    >> Share

  39. STRONGMAN H, Carreira H, De Stavola BL, Bhaskaran K, et al
    Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink.
    PLoS Med. 2022;19:e1003870.
    >> Share

  40. BHASKARAN K, Rentsch CT, Hickman G, Hulme WJ, et al
    Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform.
    PLoS Med. 2022;19:e1003871.
    >> Share

  41. QUINN KL, Bell CM
    Pandemic health consequences: Grasping the long COVID tail.
    PLoS Med. 2022;19:e1003891.
    >> Share

  42. GUROL-URGANCI I, Waite L, Webster K, Jardine J, et al
    Obstetric interventions and pregnancy outcomes during the COVID-19 pandemic in England: A nationwide cohort study.
    PLoS Med. 2022;19:e1003884.
    >> Share

    December 2021
  43. GRAM MA, Nielsen J, Schelde AB, Nielsen KF, et al
    Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
    PLoS Med. 2021;18:e1003874.
    >> Share

  44. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Coyle P, et al
    Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
    PLoS Med. 2021;18:e1003879.
    >> Share

  45. KARUNA S, Li SS, Grant S, Walsh SR, et al
    Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.
    PLoS Med. 2021;18:e1003868.
    >> Share

  46. PETERSEN M, Schwab J, Havlir DV
    SARS-CoV-2 vaccine boosters: The time to act is now.
    PLoS Med. 2021;18:e1003882.
    >> Share

  47. MURHEKAR MV, Bhatnagar T, Thangaraj JWV, Saravanakumar V, et al
    Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
    PLoS Med. 2021;18:e1003877.
    >> Share

  48. SENEFELD JW, Johnson PW, Kunze KL, Bloch EM, et al
    Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study.
    PLoS Med. 2021;18:e1003872.
    >> Share

    November 2021
  49. MARTIN CA, Marshall C, Patel P, Goss C, et al
    SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
    PLoS Med. 2021;18:e1003823.
    >> Share

  50. BHANU C, Gopal DP, Walters K, Chaudhry UAR, et al
    Vaccination uptake amongst older adults from minority ethnic backgrounds: A systematic review.
    PLoS Med. 2021;18:e1003826.
    >> Share

  51. EPELBOIN S, Labrosse J, De Mouzon J, Fauque P, et al
    Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study.
    PLoS Med. 2021;18:e1003857.
    >> Share

  52. ABDOOL KARIM SS, Kelemu S, Baxter C
    COVID-19 in Africa: Catalyzing change for sustainable development.
    PLoS Med. 2021;18:e1003869.
    >> Share

  53. SPLINTER MJ, Velek P, Ikram MK, Kieboom BCT, et al
    Prevalence and determinants of healthcare avoidance during the COVID-19 pandemic: A population-based cross-sectional study.
    PLoS Med. 2021;18:e1003854.
    >> Share

    October 2021
  54. STOVER J, Glaubius R, Teng Y, Kelly S, et al
    Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
    PLoS Med. 2021;18:e1003831.
    >> Share

  55. PEARSON CAB, Bozzani F, Procter SR, Davies NG, et al
    COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
    PLoS Med. 2021;18:e1003815.
    >> Share

  56. FORMICA N, Mallory R, Albert G, Robinson M, et al
    Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial.
    PLoS Med. 2021;18:e1003769.
    >> Share

  57. BERGQVIST R, Ahlqvist VH, Lundberg M, Hergens MP, et al
    HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study.
    PLoS Med. 2021;18:e1003820.
    >> Share

  58. GILBODY S, Littlewood E, McMillan D, Chew-Graham CA, et al
    Behavioural activation to prevent depression and loneliness among socially isolated older people with long-term conditions: The BASIL COVID-19 pilot randomised controlled trial.
    PLoS Med. 2021;18:e1003779.
    >> Share

  59. MO Y, Eyre DW, Lumley SF, Walker TM, et al
    Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study.
    PLoS Med. 2021;18:e1003816.
    >> Share

  60. IOANNOU GN, Ferguson JM, O'Hare AM, Bohnert ASB, et al
    Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study.
    PLoS Med. 2021;18:e1003807.
    >> Share

  61. POLLETT S, Johansson MA, Reich NG, Brett-Major D, et al
    Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines.
    PLoS Med. 2021;18:e1003793.
    >> Share

  62. GENG EH, Reid MJA, Goosby E, Abdool-Karim Q, et al
    COVID-19 and global equity for health: The good, the bad, and the wicked.
    PLoS Med. 2021;18:e1003797.
    >> Share

    September 2021
  63. FIGUEROA JP, Hotez PJ, Batista C, Ben Amor Y, et al
    Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed.
    PLoS Med. 2021;18:e1003772.
    >> Share

  64. MUTHUKUMAR AV, Morrell W, Bierer BE
    Evaluating the frequency of English language requirements in clinical trial eligibility criteria: A systematic analysis using
    PLoS Med. 2021;18:e1003758.
    >> Share

  65. ELLIOTT J, Whitaker M, Bodinier B, Eales O, et al
    Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people.
    PLoS Med. 2021;18:e1003777.
    >> Share

  66. TAQUET M, Dercon Q, Luciano S, Geddes JR, et al
    Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
    PLoS Med. 2021;18:e1003773.
    >> Share

  67. ADAM M, Johnston J, Job N, Dronavalli M, et al
    Evaluation of a community-based mobile video breastfeeding intervention in Khayelitsha, South Africa: The Philani MOVIE cluster-randomized controlled trial.
    PLoS Med. 2021;18:e1003744.
    >> Share

    August 2021
  68. BRUMMER LE, Katzenschlager S, Gaeddert M, Erdmann C, et al
    Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003735.
    >> Share

  69. KILMARX PH, Glass RI
    Building global health research capacity to address research imperatives following the COVID-19 pandemic.
    PLoS Med. 2021;18:e1003753.
    >> Share

    July 2021
  70. SULIS G, Batomen B, Kotwani A, Pai M, et al
    Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis.
    PLoS Med. 2021;18:e1003682.
    >> Share

  71. IWANAMI S, Ejima K, Kim KS, Noshita K, et al
    Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study.
    PLoS Med. 2021;18:e1003660.
    >> Share

  72. KANDULA S, Shaman J
    Investigating associations between COVID-19 mortality and population-level health and socioeconomic indicators in the United States: A modeling study.
    PLoS Med. 2021;18:e1003693.
    >> Share

    June 2021
  73. BUTLER-LAPORTE G, Nakanishi T, Mooser V, Morrison DR, et al
    Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.
    PLoS Med. 2021;18:e1003605.
    >> Share

  74. INZAULE SC, Ondoa P, Loembe MM, Tebeje YK, et al
    COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control.
    PLoS Med. 2021;18:e1003666.
    >> Share

  75. MAO W, Ogbuoji O, Watkins D, Bharali I, et al
    Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.
    PLoS Med. 2021;18:e1003675.
    >> Share

    May 2021
  76. GOLDMAN M, Hermans C
    Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity.
    PLoS Med. 2021;18:e1003648.
    >> Share

  77. STOKES AC, Lundberg DJ, Elo IT, Hempstead K, et al
    COVID-19 and excess mortality in the United States: A county-level analysis.
    PLoS Med. 2021;18:e1003571.
    >> Share

    April 2021
  78. KRISHNAN A, Dar L, Saha S, Narayan VV, et al
    Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial.
    PLoS Med. 2021;18:e1003609.
    >> Share

  79. ABIMBOLA S, Asthana S, Montenegro C, Guinto RR, et al
    Addressing power asymmetries in global health: Imperatives in the wake of the COVID-19 pandemic.
    PLoS Med. 2021;18:e1003604.
    >> Share

  80. GRANTZ KH, Lee EC, D'Agostino McGowan L, Lee KH, et al
    Maximizing and evaluating the impact of test-trace-isolate programs: A modeling study.
    PLoS Med. 2021;18:e1003585.
    >> Share

    March 2021
  81. LAFOND KE, Porter RM, Whaley MJ, Suizan Z, et al
    Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003550.
    >> Share

  82. BALCELLS ME, Rojas L, Le Corre N, Martinez-Valdebenito C, et al
    Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.
    PLoS Med. 2021;18:e1003415.
    >> Share

  83. REID M, Abdool-Karim Q, Geng E, Goosby E, et al
    How will COVID-19 transform global health post-pandemic? Defining research and investment opportunities and priorities.
    PLoS Med. 2021;18:e1003564.
    >> Share

  84. LEONG A, Cole JB, Brenner LN, Meigs JB, et al
    Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis.
    PLoS Med. 2021;18:e1003553.
    >> Share

    January 2021
  85. SELIGMAN B, Ferranna M, Bloom DE
    Social determinants of mortality from COVID-19: A simulation study using NHANES.
    PLoS Med. 2021;18:e1003490.
    >> Share

    December 2020
  86. KIM MS, An MH, Kim WJ, Hwang TH, et al
    Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
    PLoS Med. 2020;17:e1003501.
    >> Share

    October 2020
  87. MAKARONIDIS J, Mok J, Balogun N, Magee CG, et al
    Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study.
    PLoS Med. 2020;17:e1003358.
    >> Share

  88. MCKEIGUE PM, Weir A, Bishop J, McGurnaghan SJ, et al
    Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.
    PLoS Med. 2020;17:e1003374.
    >> Share

  89. BASSETT MT, Chen JT, Krieger N
    Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.
    PLoS Med. 2020;17:e1003402.
    >> Share

  90. KOLHE NV, Fluck RJ, Selby NM, Taal MW, et al
    Acute kidney injury associated with COVID-19: A retrospective cohort study.
    PLoS Med. 2020;17:e1003406.
    >> Share

    September 2020
  91. LUND LC, Kristensen KB, Reilev M, Christensen S, et al
    Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
    PLoS Med. 2020;17:e1003308.
    >> Share

  92. WHITE NJ, Watson JA, Hoglund RM, Chan XHS, et al
    COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
    PLoS Med. 2020;17:e1003252.
    >> Share

  93. HARRISON SL, Fazio-Eynullayeva E, Lane DA, Underhill P, et al
    Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.
    PLoS Med. 2020;17:e1003321.
    >> Share

  94. BUITRAGO-GARCIA D, Egli-Gany D, Counotte MJ, Hossmann S, et al
    Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.
    PLoS Med. 2020;17:e1003346.
    >> Share

  95. RENTSCH CT, Kidwai-Khan F, Tate JP, Park LS, et al
    Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study.
    PLoS Med. 2020;17:e1003379.
    >> Share

  96. JUUL S, Nielsen EE, Feinberg J, Siddiqui F, et al
    Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    PLoS Med. 2020;17:e1003293.
    >> Share

  97. STOWE J, Andrews N, Gringras P, Quinnell T, et al
    Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study.
    PLoS Med. 2020;17:e1003225.
    >> Share

    August 2020
  98. BENJAMIN-CHUNG J, Arnold BF, Kennedy CJ, Mishra K, et al
    Evaluation of a city-wide school-located influenza vaccination program in Oakland, California, with respect to vaccination coverage, school absences, and laboratory-confirmed influenza: A matched cohort study.
    PLoS Med. 2020;17:e1003238.
    >> Share

  99. SIEDNER MJ, Harling G, Reynolds Z, Gilbert RF, et al
    Social distancing to slow the US COVID-19 epidemic: Longitudinal pretest-posttest comparison group study.
    PLoS Med. 2020;17:e1003244.
    >> Share

  100. HARRINGTON DM, O'Reilly M
    The reimagination of school-based physical activity research in the COVID-19 era.
    PLoS Med. 2020;17:e1003267.
    >> Share

    July 2020
  101. SAVICKAS V, Stewart AJ, Rees-Roberts M, Short V, et al
    Opportunistic screening for atrial fibrillation by clinical pharmacists in UK general practice during the influenza vaccination season: A cross-sectional feasibility study.
    PLoS Med. 2020;17:e1003197.
    >> Share

  102. TESLYA A, Pham TM, Godijk NG, Kretzschmar ME, et al
    Impact of self-imposed prevention measures and short-term government-imposed social distancing on mitigating and delaying a COVID-19 epidemic: A modelling study.
    PLoS Med. 2020;17:e1003166.
    >> Share

  103. PINOTTI F, Di Domenico L, Ortega E, Mancastroppa M, et al
    Tracing and analysis of 288 early SARS-CoV-2 infections outside China: A modeling study.
    PLoS Med. 2020;17:e1003193.
    >> Share

  104. WU YT, Liu J, Xu JJ, Chen YF, et al
    Neonatal outcome in 29 pregnant women with COVID-19: A retrospective study in Wuhan, China.
    PLoS Med. 2020;17:e1003195.
    >> Share

  105. HAUSER A, Counotte MJ, Margossian CC, Konstantinoudis G, et al
    Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.
    PLoS Med. 2020;17:e1003189.
    >> Share

  106. ZHANG L, Tao Y, Shen M, Fairley CK, et al
    Can self-imposed prevention measures mitigate the COVID-19 epidemic?
    PLoS Med. 2020;17:e1003240.
    >> Share

  107. ADAMS J
    Addressing socioeconomic inequalities in obesity: Democratising access to resources for achieving and maintaining a healthy weight.
    PLoS Med. 2020;17:e1003243.
    >> Share

    June 2020
  108. TRUELOVE S, Abrahim O, Altare C, Lauer SA, et al
    The potential impact of COVID-19 in refugee camps in Bangladesh and beyond: A modeling study.
    PLoS Med. 2020;17:e1003144.
    >> Share

  109. ZHANG C, Gu J, Chen Q, Deng N, et al
    Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series.
    PLoS Med. 2020;17:e1003130.
    >> Share

    Will COVID-19 be evidence-based medicine's nemesis?
    PLoS Med. 2020;17:e1003266.
    >> Share

    May 2020
  111. KAZATCHKINE MD, Goldman M, Vincent JL
    Antibody-based therapies for COVID-19: Can Europe move faster?
    PLoS Med. 2020;17:e1003127.
    >> Share

  112. Pandemic preparedness and responses: WHO to turn to in a crisis?
    PLoS Med. 2020;17:e1003167.
    >> Share

    April 2020

  113. Pandemic responses: Planning to neutralize SARS-CoV-2 and prepare for future outbreaks.
    PLoS Med. 2020;17:e1003123.
    >> Share

    March 2020
  114. FORSTER AH, Witham K, Depelsenaire ACI, Veitch M, et al
    Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
    PLoS Med. 2020;17:e1003024.
    >> Share

    January 2020
  115. SHEARER FM, Moss R, McVernon J, Ross JV, et al
    Infectious disease pandemic planning and response: Incorporating decision analysis.
    PLoS Med. 2020;17:e1003018.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016